Mushonga wegomarara remuromo wechibereko

Share This Post

Pane here muganho wezera rekubaya gomarara remuromo wechibereko?

Mushonga wekutanga wakatenderwa HPV wekudzivirira gomarara remuchibereko wakaparurwa zviri pamutemo pamusika. Izvi zvisati zvaitika, nzira huru yekudzivirira gomarara remuromo wechibereko yaive yekuongorora muromo wechibereko. 
CCTV Finance yakambotaura kuti mushonga uyu "Sirius" wekambani yeBritish inogadzira mishonga GlaxoSmithKline-mutengo unokakavara wemhando mbiri dzehutachiona (HPV-16 neHPV-18) dzinogona kukonzera gomarara remuchibereko uye mushonga wekudzivirira zvakanyanya. 
Nezve chirevo chekuti zera rakanakisa rekudzivirira iri makore 9 kusvika makumi maviri nemashanu, Zhang Youzhong, mutevedzeri wemukuru weDhipatimendi reGynecology uye Oncology, Qilu Hospital yeShandong University, akadaro mukubvunzana neQilu Evening News kuti kunyangwe apera Makore makumi maviri nemashanu ekuberekwa, kana asina kutapukirwa nehutachiona hweHIVV, Kana kuti haina kutapukirwa nemavhairasi maviri ataurwa pamusoro apa uye achiri kugona kuiswa jekiseni. China’s annual chirwere chemuviri wechibereko cases account for more than 28% of the world’s, and it is one of the most common malignant tumors for women. Globally, cervical cancer is also the third most common cancer among women aged 15 to 44. 
Nyanzvi: Pane zviitiko zvitatu zvinopfuura zera ramakore makumi maviri nemashanu. Iwe unogona zvakare kufonera iyo
yepamutemo webhusaiti yeHurumende Chikafu neDrug Administration kuratidza kuti HPV Chinese iri akadana  hutachiona hwevanhu papilloma. Mazhinji emarudzi anozivikanwa anodarika zana marudzi eHIVV "ane njodzi shoma" uye haabatanidzwe negomarara remuchibereko, asi gumi nemana acho anoiswa se "njodzi huru" uye maviri ematambudziko akanyanya (HPV-100 Type uye HPV- 14 mhando) inogona kukonzera 16% yekenza yemuromo wechibereko. 
Makore akakwana ekubaiwa jekiseni rekudzivirira "Cirius" ino inguva yemakore mapfumbamwe kusvika makumi maviri nemashanu ekuberekwa. Vazhinji pamusoro-zera netizens vakaratidza kuzvidemba. Vanhu vanopfuura makore makumi maviri nemashanu vanogona kubayiwa here? 
Musi waAugust 3, Zhang Youzhong, mutevedzeri wemutungamiriri weDhipatimendi reGynecologic Oncology paQilu Hospital yeShandong University, akataura mubvunzurudzo neQilu Evening News kuti makore 9-25 ekuberekwa anogona kungonzwisiswa sezera rakanakisa rekubaiwa. Ichokwadi, pane zviitiko zvitatu apo jekiseni iri richiri kubayiwa: imwe ndeyekuti kunyangwe iri pamusoro pemakore makumi maviri nemashanu, haina kubatwa nehutachiona hweHIVV; imwe ndeyekuti yakatapukirwa nehutachiona hweHIVV, asi haina kutapukirwa nemhando mbiri dzeutachiona hweHIVV, 25, 16; Chechitatu ndechekuti kunyangwe hvv yakatapukirwa uye maronda ane chirwere checancer yemukondombera zvaitika, yadzokazve uye yaita makore. 
Zvinoenderana neruzivo rweveruzhinji rwunopihwa neHurumende Chikafu neDrug Administration, hutachiona hweHIVV hwanyanya pakati pevakadzi. Dhata dzinoratidza kuti pane imwe nhanho muhupenyu, vakadzi vana pavashanu vanozotapukirwa. Kana iwe uine hutachiona hune njodzi yakakura yeHIVV, inogona kufambira mberi kusvika padanho repamusoro rezvipembenene zvemuchibereko kana kutokura kuita gomarara remuromo wechibereko. 
HPV inonyanya kutapuriranwa kuburikidza nekusangana pabonde, uye inogona zvakare kutapukirwa kuburikidza nekubatana chaiko: semuenzaniso, mushure mekubata chinhu neHIVV muruoko rwako, unogona kuunza hutachiona munhengo dzekubereka panguva yekugeza kana kugeza; kana kana nhengo yekubereka ikaonekwa kune HPV Zvinhu zvakaita sematauro ekugezesa anogona kutapukirwa. 
Mushonga wequadrivalent unotarisirwa kunyorwa munguva. 
Zvinoenderana neCCTV Financial Reports, iyo general cervical jekiseni regomarara yakakamurwa kuita mbiri, ina, uye mipfumbamwe mitengo. Panguva ino inotenderwa kutengeswa muMainland. IGlaxoSmithKline's HPV bivalent vaccine. 
Qiao Youlin, director weCancer Epidemiology Laboratory yeChinese Academy yeMedical Sayenzi, akataura mubvunzurudzo neCCTV News kuti muna Chivabvu gore rino, jekiseni requadrivalent (rakavakirwa pamushonga unodzivirira, hutachiona hweHIVV huviri hwakanangwa, nezera rinoshanda ane makore makumi maviri kusvika makumi mana nemashanu) Yakagamuchirwa nehurumende uye inotarisirwa kuverengerwa mukupera kwegore. 
Kana iri iyo veruzhinji vanogona kushandisa vaccine-valent vaccine, Qiao Youlin akati vaccine-valent vaccine haisati yapinda mumakiriniki, uye nguva inotarisirwa "yakareba kwazvo." 
Ko mushonga weHPV uchabatanidzwa muinishuwarenzi yekurapa munguva pfupi iri kutevera? Zhao Fanghui, mutevedzeri wedhairekita, purofesa uye mudzidzisi wechiremba weDhipatimendi reCancer Epidemiology, Cancer Hospital, Chinese Academy yeMedical Sayenzi, anotenda kuti hazviite kuti mutengo wejekiseni udzikiswe kuburikidza nemakwikwi emusika, uyezve uchavharwa. neinishuwarenzi yekurapa. 
Nezve majekiseni emukondombera, State Food and Drug Administration yakayeuchidza kuti sezvo paine anopfuura gumi ane njodzi huru dzehutachiona hweHIVV hune chekuita negomarara remuromo wechibereko, uye majekiseni acho anongonangidzirwa kune mamwe acho, kunyangwe kana achibaiwa jekiseni. zvichiri kugara uchiongorora.

Subscribe To Newsletter Vedu

Wana zvigadziriso uye usambopotsa blog kubva kuCancerfax

Zvimwe Kuti Uongorore

Kurapa Kwemasero eCAR T kunoitwa nevanhu: Kubudirira Uye Zvinetso
CAR T-Cell kurapa

Kurapa Kwemasero eCAR T: Kubudirira uye Zvinetso

Human-based CAR T-cell therapy inosandura kurapwa kwegomarara nekugadzirisa magene masero emuviri emurwere kuti anange nekuparadza maseru egomarara. Nekushandisa simba rekudzivirira kwemuviri, marapirwo aya anopa marapiro ane simba uye emunhu ane mukana wekuregererwa kwenguva refu mumhando dzakasiyana dzegomarara.

Kunzwisisa Cytokine Release Syndrome: Zvinokonzera, Zviratidzo, uye Kurapa
CAR T-Cell kurapa

Kunzwisisa Cytokine Release Syndrome: Zvinokonzera, Zviratidzo, uye Kurapa

Cytokine Release Syndrome (CRS) is immune system reaction inowanzo kukonzerwa nemamwe marapirwo senge immunotherapy kana CAR-T cell therapy. Zvinosanganisira kuburitswa kwakanyanya kwemacytokines, zvichikonzera zviratidzo kubva pafivha uye kuneta kusvika kune zvinogona kuuraya hupenyu sekukuvadzwa kwenhengo. Kutungamira kunoda kunyatsotarisisa uye nzira dzekupindira.

Kuda rubatsiro? Chikwata chedu chakagadzirira kukubatsira.

Tinoshuvira kupora nekukurumidza kwemudiwa wako uye padyo neuyo.

Kutanga kutaura
Tiri paIndaneti! Taura Nesu!
Skena kodhi
Mhoro,

Kugamuchirwa kuCancerFax!

CancerFax ipuratifomu yekupayona yakatsaurirwa kubatanidza vanhu vakatarisana negomarara repamberi nekurapa kwesero seCAR T-Cell therapy, TIL kurapwa, uye miedzo yekiriniki pasi rese.

Tizivise zvatinogona kukuitira.

1) Kurapwa kwegomarara kunze kwenyika?
2) CAR T-Cell therapy
3) Mushonga wegomarara
4) Online vhidhiyo kubvunza
5) Proton kurapwa